<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27472280</article-id><article-id pub-id-type="pmc">4966948</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0160149</article-id><article-id pub-id-type="publisher-id">PONE-D-16-10242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Tuberculosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Tuberculosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Actinobacteria</subject><subj-group><subject>Mycobacterium Tuberculosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Preventive Medicine</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject><subj-group><subject>Genetic Mapping</subject><subj-group><subject>Variant Genotypes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug Research and Development</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Clinical Trials</subject><subj-group><subject>Randomized Controlled Trials</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Body Mass Index</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Body Mass Index</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Hematology</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Revisiting the Heterogeneous IFN-&#x003b3; Response of Bacille of Calmette-Gu&#x000e9;rin (BCG)-Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the <italic>IFNG</italic>+874 A/T Polymorphism</article-title><alt-title alt-title-type="running-head"><italic>IFNG</italic>+874 A/T Polymorphism and BMI in a BCG Revaccination Trial</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Concei&#x000e7;&#x000e3;o</surname><given-names>Elisabete L.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nascimento-Sampaio</surname><given-names>Francisco S.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schwingel</surname><given-names>Paulo A.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="author-notes" rid="currentaff001"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Evelin S.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>Michael S.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vieira</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mendes</surname><given-names>Carlos M. C.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Souza-Machado</surname><given-names>Adelmir</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Martha M.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Barral-Netto</surname><given-names>Manoel</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marinho</surname><given-names>Jamocyr M.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1928-0404</contrib-id><name><surname>Barbosa</surname><given-names>Theolis</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Universidade Federal da Bahia, Salvador, BA, Brazil</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Instituto Gon&#x000e7;alo Moniz, Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Salvador, BA, Brazil</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Escola Bahiana de Medicina e Sa&#x000fa;de P&#x000fa;blica, Salvador, BA, Brazil</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Hospital Santa Izabel, Salvador, BA, Brazil</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rawkins</surname><given-names>Ann</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Public Health England, UNITED KINGDOM</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: ELC PAS TB. Performed the experiments: ELC FSN-S ESO MSR IV. Analyzed the data: ELC FSN-S PAS ESO CMCM AS-M MMO MB-N JMM TB. Contributed reagents/materials/analysis tools: PAS CMCM MMO MB-N TB. Wrote the paper: ELC FSN-S PAS CMCM TB. Subjects&#x02019; recruitment and follow-up: ELC FSN-S ESO MSR IV JMM TB.</p></fn><fn fn-type="current-aff" id="currentaff001"><label>&#x000a4;</label><p>Current address: Campus Petrolina, Universidade de Pernambuco, Petrolina, PE, Brazil</p></fn><corresp id="cor001">* E-mail: <email>theolis@bahia.fiocruz.br</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>7</issue><elocation-id>e0160149</elocation-id><history><date date-type="received"><day>10</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Concei&#x000e7;&#x000e3;o et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Concei&#x000e7;&#x000e3;o et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0160149.pdf"/><abstract><p>In trials evaluating the immune responses to Bacille of Calmette-Gu&#x000e9;rin (BCG), the genetic background and the nutritional status are host-related factors that could affect the heterogeneity in these parameters. The <italic>IFNG</italic>+874 A/T (rs 62559044) polymorphism has been reported to influence the IFN-&#x003b3; production by BCG-vaccinated individuals challenged in vitro with mycobacterial antigens. The body mass index (BMI) is a proxy for the nutritional status and has been associated both with the susceptibility to tuberculosis and with the IFN-&#x003b3; response. We show that although the <italic>IFNG</italic>+874 A/T polymorphism was not associated with the heterogeneity of IFN-&#x003b3; production in a randomized controlled trial that evaluated long-term immune responses to BCG revaccination previously conducted in Salvador, Bahia, Brazil, the effect of this polymorphism on the observed increase in IFN-&#x003b3; production among revaccinated subjects was adjusted in individuals with a low BMI.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Funda&#x000e7;&#x000e3;o&#x000a0;de&#x000a0;Amparo&#x000a0;&#x000e0;&#x000a0;Pesquisa&#x000a0;do&#x000a0;Estado&#x000a0;da Bahia (BR)</institution></funding-source><award-id>002/03-PPP</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1928-0404</contrib-id><name><surname>Barbosa</surname><given-names>Theolis</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia&#x02014;FAPESB (002/03-PPP). ELC received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior&#x02014;CAPES. ESO and MSR received scholarships from FAPESB. TB was a senior investigator from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico&#x02014;CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="9"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The Bacille of Calmette-Gu&#x000e9;rin (BCG) vaccine has been the subject of numerous efficacy trials and epidemiological studies conducted over several decades. These trials indicate that the neonatal vaccination with BCG has 40&#x02013;80% protective efficacy against tuberculosis (TB), being particularly effective against the meningeal and miliary forms of the disease, and its efficacy against the pulmonary form varies geographically [<xref rid="pone.0160149.ref001" ref-type="bibr">1</xref>]. New vaccines against TB are under trial [<xref rid="pone.0160149.ref002" ref-type="bibr">2</xref>], and the establishment of biomarkers of vaccine-induced protection could accelerate their evaluation. The study of the immune response to BCG in vaccine trials can yield important insights relative to the appropriateness of putative biomarkers of protection against TB, given the fact that BCG is the only vaccine to date proven to be protective against the disease. A putative marker related with the anti-mycobacterial response is IFN-&#x003b3;. There is evidence relating the IFN-&#x003b3; production with reduced disease burden in experimental disease [<xref rid="pone.0160149.ref003" ref-type="bibr">3</xref>] and in humans [<xref rid="pone.0160149.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0160149.ref006" ref-type="bibr">6</xref>], but the in vitro IFN-&#x003b3; production against mycobacterial antigen(s) and the expansion of IFN-&#x003b3;-producing antigen-specific cells do not always correlate with vaccine-induced protection against TB [<xref rid="pone.0160149.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0160149.ref008" ref-type="bibr">8</xref>].</p><p>The genetic background of BCG-vaccinated individuals may influence the amplitude of the post-vaccination IFN-&#x003b3; response. The T&#x0003e;A single nucleotide polymorphism (SNP) of <italic>IFNG</italic> in the +874 position is one of the best studied polymorphisms that affect the IFN-&#x003b3; production [<xref rid="pone.0160149.ref009" ref-type="bibr">9</xref>], and it has been associated both with the occurrence of active TB [<xref rid="pone.0160149.ref010" ref-type="bibr">10</xref>] and with lower IFN-&#x003b3; production in TB patients [<xref rid="pone.0160149.ref009" ref-type="bibr">9</xref>] and in BCG-vaccinated children [<xref rid="pone.0160149.ref011" ref-type="bibr">11</xref>]. Likewise, malnutrition has been related with an increased risk of tuberculosis development [<xref rid="pone.0160149.ref012" ref-type="bibr">12</xref>]. A recent study conducted in Taiwan showed that body mass index (BMI) values at the beginning of the anti-tuberculosis treatment related with mortality caused by tuberculosis among male patients [<xref rid="pone.0160149.ref013" ref-type="bibr">13</xref>]. Also the production of pro-inflammatory cytokines including IFN-&#x003b3; is impaired in <italic>Mycobacterium tuberculosis</italic>-infected underweight individuals [<xref rid="pone.0160149.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0160149.ref015" ref-type="bibr">15</xref>].</p><p>A randomized controlled trial to evaluate the immune response to BCG revaccination was conducted in Salvador, Bahia, Brazil [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>]. The volunteers enrolled in the trial were undergraduate students from two universities with a short age range, without TB infection, with high socioeconomic level, no HIV infection, no contact with tuberculosis patients and with normal complete blood counts and hematocrit. The IFN-&#x003b3; response to BCG revaccination in the interval of two months after the intervention varied widely (from 0.1 to 100 fold in the revaccinated group, compared with a range of 0.1&#x02013;7.1 in the control group), and was associated with the capacity of producing high levels of IFN-&#x003b3; at 12-months follow-up. The study was not designed to make it possible to correlate the IFN-&#x003b3; response with protection conferred by revaccination. In a previous trial conducted in the same city BCG revaccination had a modest protective effect over the neonatal BCG vaccine [<xref rid="pone.0160149.ref017" ref-type="bibr">17</xref>]. We discuss the possible role of <italic>IFNG</italic> +874 polymorphism and BMI on the observed heterogeneous IFN-&#x003b3; production to in vitro stimulation with mycobacterial antigens in this trial [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>].</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Recruitment and study design</title><p>To investigate the association of the <italic>IFNG</italic>+874 T&#x0003e;A polymorphism with the IFN-&#x003b3; response to <italic>Mycobacterium tuberculosis</italic> we compared four groups:</p><list list-type="bullet"><list-item><p>Twenty-nine volunteers with distinguishable BCG vaccination scars randomly assigned to the control group in a randomized controlled trial to assess the IFN-&#x003b3; response after BCG revaccination performed in Salvador, Bahia, Brazil [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>].</p></list-item><list-item><p>Forty-six volunteers with distinguishable BCG vaccination scars randomly assigned to be revaccinated in the same trial [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>].</p></list-item><list-item><p>LTBI, comprised of 66 latently infected individuals identified by routine tuberculin skin test of undergraduate health care students involved in patients&#x02019; follow-up at the Hospital Especializado Octavio Mangabeira, Salvador, Bahia, Brazil (the state reference hospital for tuberculosis diagnosis and treatment). Subjects were considered positive if they had induration above 10 mm.</p></list-item><list-item><p>TB, comprised of 93 individuals with active pulmonary tuberculous disease, newly diagnosed by positive smear and/or culture for <italic>Mycobacterium tuberculosis</italic> at the Hospital Especializado Octavio Mangabeira.</p></list-item></list><p>This study was approved by the Ethical Committee of the Centro de Pesquisas Goncalo Moniz (CEP-CPQGM/FIOCRUZ, CAAE: 0015.0.225.000&#x02013;10 and 0005.0.225.000&#x02013;11), and complied with the ethical principles contained in the Brazilian National Health Council Resolution 196/96 Guidelines.</p></sec><sec id="sec004"><title>Cultures and IFN-y production</title><p>Whole blood cultures were performed from vacuum-collected heparin treated blood, with or without mycobacterial antigen (10 &#x003bc;g/ml of <italic>Mycobacterium tuberculosis</italic> H37Rv culture lysate, Mtb, kindly provided by the Colorado State University, USA as part of NIH, NIAID Contract No. HHSN266200400091C, entitled "Tuberculosis Vaccine Testing and Research Materials", which was awarded to Colorado State University), and IFN-&#x003b3; was measured in the culture supernatants as described in [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>].</p></sec><sec id="sec005"><title>Genotyping</title><p>Genomic DNA was successfully obtained for 25 revaccinated (8 male, 32%), 15 control (5 male, 33%), 66 LTBI (18 male, 27%) and 93 TB (64 male, 69%) volunteers. In this sample, height and weight values were not registered for one control (female) and five TB (3 male) participants. Height was not registered for one revaccinated (female), one LTBI (female), and 13 TB (7 male) participants. Weight was not registered for one TB (male) participant. Baseline IFN-&#x003b3; production was evaluated for all revaccinated and control volunteers, as well as for 57 LTBI (among which 11 participants with values of IFN-&#x003b3; in stimulated cultures that exceeded the maximum optical density of the standard curve), and 45 TB participants. IFN-&#x003b3; production 2 months after intervention was available for 23 revaccinated and 8 control participants. Genomic DNA was obtained using the phenol-chloroform method. The <italic>IFNG</italic>+874 A/T polymorphism was investigated by Amplification Refractory Mutation System (ARMS-PCR) as previously described [<xref rid="pone.0160149.ref018" ref-type="bibr">18</xref>]. Briefly, to assess the presence of the A Allele, the primer IFN-&#x003b3; G: 5&#x02019;-TCA ACA AAG CTG ATA CTC CA-3&#x02019;; and the primer IFN-&#x003b3; A: 5&#x02019;-TTC TTA CAA CAC AAA ATC AAA TCA-3&#x02019; were used. For the T Allele, the primer IFN-&#x003b3; G was used with the primer IFN-&#x003b3; T: 5&#x02019;-TTC TTA CAA CAC AAA ATC AAA TCT-3&#x02019;. Both reactions produce a 295-bp fragment. Amplification was performed under the following conditions: 12 &#x003bc;L reaction containing approximately 100 ng genomic DNA, 1&#x003bc;M of each primer pair, 10X buffer, MgCl2 50 mM, dNTP 25 mM and 5U/&#x003bc;L of Taq polymerase. The interpretation of the results was based on the presence or absence of the amplified product, which was confirmed on 2% agarose gel stained with ethidium bromide (1&#x003bc;g/mL).</p></sec><sec id="sec006"><title>Statistical Analyses</title><p>The cytokine levels and ratios were compared between 2 groups using the Mann-Whitney U test for unpaired samples. All genotypes were tested for the Hardy&#x02013;Weinberg equilibrium using a chi-square-test between observed and expected numbers. The Fisher&#x02019;s exact test was applied to compare <italic>IFNG</italic> +874T/A SNP mutation frequency between the groups. The tentative Poisson model was used to evaluate the interaction among the IFN-y production and the variables genotype, sex and BMI. To assess the association among the genotypes AA and TT/TA and the ratio in the IFN-&#x003b3; production (T0/T2 &#x02265;3,3) we performed the Poisson regression. The Crude Coefficient from Poisson regression model was calculated to analyze the influence of the genotypes on the IFN-y production [<xref rid="pone.0160149.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0160149.ref020" ref-type="bibr">20</xref>]. We evaluated the quality of model adjustment through Akaike information criterion (AIC), residual analysis and Variance inflation factor (Vif) [<xref rid="pone.0160149.ref021" ref-type="bibr">21</xref>]. The analyses were performed only in the revaccinated group, restricted to the most important variables, given the sample size. Age, body mass index (BMI [<xref rid="pone.0160149.ref022" ref-type="bibr">22</xref>]), and cytokine levels of the volunteers are presented as mean (95% confidence interval, CI) values. Databanks were mounted in EpiData Entry (version, EpiData Association, Denmark), and data were processed and analyzed using R (version 3.1) [<xref rid="pone.0160149.ref023" ref-type="bibr">23</xref>], EpiData Analysis (version) and Prism (version, GraphPad Inc., San Diego, CA).</p></sec></sec><sec id="sec007"><title>Results and Discussion</title><sec id="sec008"><title>Association between the IFN-&#x003b3; production and the <italic>IFNG</italic>+874 polymorphism</title><p>The allelic and genotypic frequencies for the <italic>IFNG</italic>+874 polymorphism agreed with those found for the Brazilian population [<xref rid="pone.0160149.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0160149.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0160149.ref025" ref-type="bibr">25</xref>] and elsewhere [<xref rid="pone.0160149.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0160149.ref027" ref-type="bibr">27</xref>]. The A allele was the most frequent and there were no differences in its frequency between the groups evaluated (<xref ref-type="table" rid="pone.0160149.t001">Table 1</xref>). The TA genotype was the most frequent, followed by the AA genotype. The genotypic frequencies also did not differ between the groups. The individuals in all groups were stratified according to the <italic>IFNG</italic>+874 genotype: AA and TT/TA. The IFN-&#x003b3; production at baseline (<xref ref-type="fig" rid="pone.0160149.g001">Fig 1A</xref>) and the ratio of the IFN-&#x003b3; concentration measured in the 2-month follow-up culture divided by the IFN-&#x003b3; concentration measured in the baseline culture (T2/T0 IFN-&#x003b3; ratio) (<xref ref-type="fig" rid="pone.0160149.g001">Fig 1B</xref>) did not differ between these two strata for the revaccinated subjects. Individuals with T2/T0 IFN-&#x003b3; ratio above the cut-off of 3.262 ("high-ratio") were 4.7 times more likely to produce IFN-&#x003b3; above the median for the revaccinated group one year after intervention than individuals with T2/T0 IFN-&#x003b3; ratio below this cut-off (&#x0201c;low ratio&#x0201d;) [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>]. Furthermore, high-ratio revaccinated individuals were 7.1 times more likely to have IFN-&#x003b3; production above that found for controls plus twice the standard deviation one year after the intervention [<xref rid="pone.0160149.ref016" ref-type="bibr">16</xref>].</p><fig id="pone.0160149.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160149.g001</object-id><label>Fig 1</label><caption><p><bold>Genotype distribution of IFN-&#x003b3; production (A, C, D) or T2/T0 IFN-&#x003b3; ratio (B) in whole blood cultures stimulated with mycobacterial antigen.</bold> (A, B) BCG-revaccinated subjects; A depicts IFN-&#x003b3; production at baseline. (C) LTBI volunteers. (D) TB volunteers.</p></caption><graphic xlink:href="pone.0160149.g001"/></fig><table-wrap id="pone.0160149.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160149.t001</object-id><label>Table 1</label><caption><title>Distribution of genotypic and allelic frequencies of the <italic>IFNG</italic>+874T/A in the individuals involved in the BCG revaccination trial and in the comparison groups (LTBI and TB).</title></caption><alternatives><graphic id="pone.0160149.t001g" xlink:href="pone.0160149.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="center" colspan="3" rowspan="1">Genotype frequency<xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></th><th align="center" colspan="2" rowspan="1">Allele frequency<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref></th></tr><tr><th align="center" rowspan="1" colspan="1">TT (%)</th><th align="center" rowspan="1" colspan="1">TA (%)</th><th align="center" rowspan="1" colspan="1">AA (%)</th><th align="center" rowspan="1" colspan="1">T (%)</th><th align="center" rowspan="1" colspan="1">A (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Revaccinated (N = 25)</bold></td><td align="center" rowspan="1" colspan="1">2 (8)</td><td align="center" rowspan="1" colspan="1">15 (60)</td><td align="center" rowspan="1" colspan="1">8 (32)</td><td align="center" rowspan="1" colspan="1">19 (38)</td><td align="center" rowspan="1" colspan="1">31 (62)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Controls (N = 15)</bold></td><td align="center" rowspan="1" colspan="1">1 (7)</td><td align="center" rowspan="1" colspan="1">10 (67)</td><td align="center" rowspan="1" colspan="1">4 (27)</td><td align="center" rowspan="1" colspan="1">12 (40)</td><td align="center" rowspan="1" colspan="1">18 (60)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>LTBI (N = 66)</bold></td><td align="center" rowspan="1" colspan="1">7 (11)</td><td align="center" rowspan="1" colspan="1">39 (59)</td><td align="center" rowspan="1" colspan="1">20 (30)</td><td align="center" rowspan="1" colspan="1">53 (40)</td><td align="center" rowspan="1" colspan="1">79 (60)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>TB (N = 93)</bold></td><td align="center" rowspan="1" colspan="1">11 (12)</td><td align="center" rowspan="1" colspan="1">47 (51)</td><td align="center" rowspan="1" colspan="1">35 (38)</td><td align="center" rowspan="1" colspan="1">69 (37)</td><td align="center" rowspan="1" colspan="1">117 (63)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total (N = 199)</bold></td><td align="center" rowspan="1" colspan="1">21 (11)</td><td align="center" rowspan="1" colspan="1">111 (56)</td><td align="center" rowspan="1" colspan="1">67 (34)</td><td align="center" rowspan="1" colspan="1">153 (38)</td><td align="center" rowspan="1" colspan="1">245 (62)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup>Comparison between revaccinated and controls: &#x003c7;2 = 0.1778, P = 1.0000; Comparison between all groups: &#x003c7;2 = 2.395, P = 0.8801, AA vs TA+TT: &#x003c7;2 = 1.350, P = 0.9981.</p></fn><fn id="t001fn002"><p><sup>b</sup>Comparison between revaccinated and controls: &#x003c7;2 = 0.03160, P = 1.0000; Comparison between all groups: &#x003c7;2 = 0.3402, P = 0.9523.</p></fn></table-wrap-foot></table-wrap><p>LTBI (<xref ref-type="fig" rid="pone.0160149.g001">Fig 1C</xref>) and TB (<xref ref-type="fig" rid="pone.0160149.g001">Fig 1D</xref>) volunteers also did not present differences in IFN-&#x003b3; production according to the <italic>IFNG</italic>+874 genotype. We speculate that polymorphisms in other positions of the <italic>IFNG</italic> gene probably also did not account for the heterogeneous IFN-&#x003b3; response in our population because their frequency is low [<xref rid="pone.0160149.ref028" ref-type="bibr">28</xref>&#x02013;<xref rid="pone.0160149.ref030" ref-type="bibr">30</xref>]. A recent study using genome-wide linkage analysis showed that the IFN-&#x003b3; response of contacts of tuberculosis patients to both BCG and PPD stimulation in vitro related with the 8q11.2-8q22 region, where 108 genes are encoded including <italic>IL7</italic> and <italic>LY96</italic> [<xref rid="pone.0160149.ref031" ref-type="bibr">31</xref>].</p></sec><sec id="sec009"><title>Multivariate analysis of variables influencing the heterogeneity of the IFN-&#x003b3; response</title><p>BMI did not correlate with T2/T0 IFN-&#x003b3; ratio among revaccinated subjects (Spearman r = -0.0707, P = 0.7368). However, individuals in the revaccinated group with normal BMI had significantly higher IFN-&#x003b3; production at baseline when compared with low BMI subjects (<xref ref-type="fig" rid="pone.0160149.g002">Fig 2A</xref>). Only three individuals with LTBI had low BMI (<xref ref-type="fig" rid="pone.0160149.g002">Fig 2B</xref>). The association between BMI and IFN-&#x003b3; production was also true for the comparison group TB (<xref ref-type="fig" rid="pone.0160149.g002">Fig 2C</xref>). Therefore, we assessed the association between the T2/T0 IFN-&#x003b3; ratio and the variables BMI and genotype using a multivariate model.</p><fig id="pone.0160149.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160149.g002</object-id><label>Fig 2</label><caption><title>IFN-&#x003b3; production in whole blood cultures stimulated with mycobacterial antigen stratified by subjects&#x02019; BMI.</title><p>(A) BCG-revaccinated subjects&#x02019; baseline cultures. (B) LTBI volunteers. (C) TB volunteers. *P&#x0003c;0.05.</p></caption><graphic xlink:href="pone.0160149.g002"/></fig><p>The results of the non-adjusted model indicated that the genotype AA increased the relative risk of belonging to the low-ratio group by 2% (<xref ref-type="table" rid="pone.0160149.t002">Table 2</xref>). When the relative risk was adjusted by the BMI we observed that having a low BMI combined with the genotype AA decreased the relative risk of belonging to the low-ratio group by 11%. Significant interaction between a polymorphism in the beta chain of the IFN-&#x003b3; receptor and BMI values influencing the risk of non-Hodgkin lymphoma among women has been reported [<xref rid="pone.0160149.ref032" ref-type="bibr">32</xref>]. We have not found interaction between the polymorphism in <italic>IFNG</italic>+874 locus and BMI (&#x003b2; = 0.154; RR = 1.17, P = 0.92), however we found that BMI potentially confounded the association between the <italic>IFNG</italic>+874 polymorphism and the T2/T0 IFN-&#x003b3; ratio (<xref ref-type="table" rid="pone.0160149.t002">Table 2</xref>) diminishing the relative risk (RR) from 1.02 to 0.89 (a moderate reduction of 12.8%). We believe it would be cautious to consider BMI when describing the association between polymorphisms in the IFN-&#x003b3; axis and the IFN-&#x003b3; response. We suggest that further investigation is needed to address the influence of nutrition on the effect of these polymorphisms when evaluating clinically relevant endpoints in the response to <italic>M</italic>. <italic>tuberculosis</italic>, also further dissecting pathways related with body composition [<xref rid="pone.0160149.ref033" ref-type="bibr">33</xref>].</p><table-wrap id="pone.0160149.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0160149.t002</object-id><label>Table 2</label><caption><title>Multivariate analysis of the association between presenting a T2/T0 IFN-&#x003b3; ratio below 3.262 (low-ratio) and the variables BMI and <italic>IFNG</italic>+874 genotype.</title></caption><alternatives><graphic id="pone.0160149.t002g" xlink:href="pone.0160149.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Crude Coefficient</th><th align="center" rowspan="1" colspan="1">Crude RR</th><th align="center" rowspan="1" colspan="1">P</th><th align="center" rowspan="1" colspan="1">Adjusted Coefficient</th><th align="center" rowspan="1" colspan="1">Adjusted RR</th><th align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>(Intercepto)</bold></td><td align="center" rowspan="1" colspan="1">-0,5754</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,0840</td><td align="center" rowspan="1" colspan="1">-0,549</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0,1300</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>genotype</bold></td><td align="center" rowspan="1" colspan="1">0,0157</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,0979</td><td align="center" rowspan="1" colspan="1">-0,109</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,8700</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<bold>TT+TA</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<bold>AA</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1,02</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,89</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-0,109</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,8700</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<bold>&#x02265; 18.5</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<bold>&#x0003c; 18.5</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0,89</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Note: Akaike information criterion (AIC): crude = 44,83; adjusted = 44,49. Residues analysis: mean (variance) for the crude model: -0,007 (1,05); for the adjusted model: -0,004 (1,07). Vif: absence of co-linearity between BMI and genotype.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec010"><title>Conclusions</title><p>BMI and genotype may influence the IFN-&#x003b3; response of individuals in tuberculosis vaccine trials, but these variables were not able to explain most of the variation found in the response to the vaccine among these subjects. It is cautious to consider BMI values in studies that address the importance of the genetic background in the immune response against mycobacteria.</p></sec><sec sec-type="supplementary-material" id="sec011"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0160149.s001"><label>S1 Dataset</label><caption><title>Individual values of IFN-&#x003b3; production, <italic>IFNG</italic>+874 allele, sex, age, weight, height, and BMI for all participants in each group.</title><p>Dots represent missing data.</p><p>(XLSX)</p></caption><media xlink:href="pone.0160149.s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>To Beatriz Muller, Priscila Miranda, Gislaine Aparecida Lacerda and Paula Fernanda in contributing for technical support. To Bruno de Bezerril Andrade for critically reviewing the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0160149.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Mangtani</surname><given-names>P</given-names></name>, <name><surname>Abubakar</surname><given-names>I</given-names></name>, <name><surname>Ariti</surname><given-names>C</given-names></name>, <name><surname>Beynon</surname><given-names>R</given-names></name>, <name><surname>Pimpin</surname><given-names>L</given-names></name>, <name><surname>Fine</surname><given-names>PEM</given-names></name>, <etal>et al</etal>
<article-title>Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials</article-title>. <source>Clin Infect Dis Off Publ Infect Dis Soc Am</source>. <year>2014</year>;<volume>58</volume>: <fpage>470</fpage>&#x02013;<lpage>480</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cid/cit790">10.1093/cid/cit790</ext-link></comment></mixed-citation></ref><ref id="pone.0160149.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>P</given-names></name>, <name><surname>Kaufmann</surname><given-names>SHE</given-names></name>. <article-title>Novel vaccination strategies against tuberculosis</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2014</year>;<volume>4</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/cshperspect.a018523">10.1101/cshperspect.a018523</ext-link></comment></mixed-citation></ref><ref id="pone.0160149.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Forbes</surname><given-names>EK</given-names></name>, <name><surname>Sander</surname><given-names>C</given-names></name>, <name><surname>Ronan</surname><given-names>EO</given-names></name>, <name><surname>McShane</surname><given-names>H</given-names></name>, <name><surname>Hill</surname><given-names>AVS</given-names></name>, <name><surname>Beverley</surname><given-names>PCL</given-names></name>, <etal>et al</etal>
<article-title>Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice</article-title>. <source>J Immunol</source>. <year>2008</year>;<volume>181</volume>: <fpage>4955</fpage>&#x02013;<lpage>4964</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.181.7.4955">10.4049/jimmunol.181.7.4955</ext-link></comment>
<pub-id pub-id-type="pmid">18802099</pub-id></mixed-citation></ref><ref id="pone.0160149.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Black</surname><given-names>GF</given-names></name>, <name><surname>Weir</surname><given-names>RE</given-names></name>, <name><surname>Floyd</surname><given-names>S</given-names></name>, <name><surname>Bliss</surname><given-names>L</given-names></name>, <name><surname>Warndorff</surname><given-names>DK</given-names></name>, <name><surname>Crampin</surname><given-names>AC</given-names></name>, <etal>et al</etal>
<article-title>BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies</article-title>. <source>Lancet</source>. <year>2002</year>;<volume>359</volume>: <fpage>1393</fpage>&#x02013;<lpage>1401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(02)08353-8">10.1016/S0140-6736(02)08353-8</ext-link></comment>
<pub-id pub-id-type="pmid">11978337</pub-id></mixed-citation></ref><ref id="pone.0160149.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Lalor</surname><given-names>MK</given-names></name>, <name><surname>Floyd</surname><given-names>S</given-names></name>, <name><surname>Gorak-Stolinska</surname><given-names>P</given-names></name>, <name><surname>Ben-Smith</surname><given-names>A</given-names></name>, <name><surname>Weir</surname><given-names>RE</given-names></name>, <name><surname>Smith</surname><given-names>SG</given-names></name>, <etal>et al</etal>
<article-title>BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi</article-title>. <source>J Infect Dis</source>. <year>2011</year>;<volume>204</volume>: <fpage>1075</fpage>&#x02013;<lpage>1085</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jir515">10.1093/infdis/jir515</ext-link></comment>
<pub-id pub-id-type="pmid">21881123</pub-id></mixed-citation></ref><ref id="pone.0160149.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Hur</surname><given-names>Y-G</given-names></name>, <name><surname>Gorak-Stolinska</surname><given-names>P</given-names></name>, <name><surname>Lalor</surname><given-names>MK</given-names></name>, <name><surname>Mvula</surname><given-names>H</given-names></name>, <name><surname>Floyd</surname><given-names>S</given-names></name>, <name><surname>Raynes</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK</article-title>. <source>BMC Infect Dis</source>. <year>2014</year>;<volume>14</volume>: <fpage>184</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2334-14-184">10.1186/1471-2334-14-184</ext-link></comment>
<pub-id pub-id-type="pmid">24708690</pub-id></mixed-citation></ref><ref id="pone.0160149.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Cruz</surname><given-names>A</given-names></name>, <name><surname>Torrado</surname><given-names>E</given-names></name>, <name><surname>Carmona</surname><given-names>J</given-names></name>, <name><surname>Fraga</surname><given-names>AG</given-names></name>, <name><surname>Costa</surname><given-names>P</given-names></name>, <name><surname>Rodrigues</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells</article-title>. <source>Vaccine</source>. <year>2015</year>;<volume>33</volume>: <fpage>85</fpage>&#x02013;<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vaccine.2014.11.013">10.1016/j.vaccine.2014.11.013</ext-link></comment>
<pub-id pub-id-type="pmid">25448107</pub-id></mixed-citation></ref><ref id="pone.0160149.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Bhatt</surname><given-names>K</given-names></name>, <name><surname>Verma</surname><given-names>S</given-names></name>, <name><surname>Ellner</surname><given-names>JJ</given-names></name>, <name><surname>Salgame</surname><given-names>P</given-names></name>. <article-title>Quest for correlates of protection against tuberculosis</article-title>. <source>Clin Vaccine Immunol CVI</source>. <year>2015</year>;<volume>22</volume>: <fpage>258</fpage>&#x02013;<lpage>266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/CVI.00721-14">10.1128/CVI.00721-14</ext-link></comment>
<pub-id pub-id-type="pmid">25589549</pub-id></mixed-citation></ref><ref id="pone.0160149.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Sallakci</surname><given-names>N</given-names></name>, <name><surname>Coskun</surname><given-names>M</given-names></name>, <name><surname>Berber</surname><given-names>Z</given-names></name>, <name><surname>G&#x000fc;rkan</surname><given-names>F</given-names></name>, <name><surname>Kocamaz</surname><given-names>H</given-names></name>, <name><surname>Uysal</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response</article-title>. <source>Tuberc Edinb Scotl</source>. <year>2007</year>;<volume>87</volume>: <fpage>225</fpage>&#x02013;<lpage>230</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tube.2006.10.002">10.1016/j.tube.2006.10.002</ext-link></comment></mixed-citation></ref><ref id="pone.0160149.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Albuquerque</surname><given-names>AC de</given-names></name>, <name><surname>Rocha</surname><given-names>LQ</given-names></name>, <name><surname>Batista</surname><given-names>AH de M</given-names></name>, <name><surname>Teixeira</surname><given-names>AB</given-names></name>, <name><surname>Santos</surname><given-names>DB dos</given-names></name>, <name><surname>Nogueira</surname><given-names>N a. P</given-names></name>. <article-title>Association of polymorphism +874 A/T of interferon-&#x003b3; and susceptibility to the development of tuberculosis: meta-analysis</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. <year>2012</year>;<volume>31</volume>: <fpage>2887</fpage>&#x02013;<lpage>2895</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10096-012-1660-4">10.1007/s10096-012-1660-4</ext-link></comment>
<pub-id pub-id-type="pmid">22684265</pub-id></mixed-citation></ref><ref id="pone.0160149.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Anuradha</surname><given-names>B</given-names></name>, <name><surname>Rakh</surname><given-names>SS</given-names></name>, <name><surname>Ishaq</surname><given-names>M</given-names></name>, <name><surname>Murthy</surname><given-names>KJR</given-names></name>, <name><surname>Valluri</surname><given-names>VL</given-names></name>. <article-title>Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children</article-title>. <source>Pediatr Infect Dis J</source>. <year>2008</year>;<volume>27</volume>: <fpage>325</fpage>&#x02013;<lpage>329</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/INF.0b013e31816099e6">10.1097/INF.0b013e31816099e6</ext-link></comment>
<pub-id pub-id-type="pmid">18379373</pub-id></mixed-citation></ref><ref id="pone.0160149.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Cegielski</surname><given-names>JP</given-names></name>, <name><surname>McMurray</surname><given-names>DN</given-names></name>. <article-title>The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals</article-title>. <source>Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis</source>. <year>2004</year>;<volume>8</volume>: <fpage>286</fpage>&#x02013;<lpage>298</lpage>.</mixed-citation></ref><ref id="pone.0160149.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Yen</surname><given-names>Y-F</given-names></name>, <name><surname>Chuang</surname><given-names>P-H</given-names></name>, <name><surname>Yen</surname><given-names>M-Y</given-names></name>, <name><surname>Lin</surname><given-names>S-Y</given-names></name>, <name><surname>Chuang</surname><given-names>P</given-names></name>, <name><surname>Yuan</surname><given-names>M-J</given-names></name>, <etal>et al</etal>
<article-title>Association of Body Mass Index With Tuberculosis Mortality: A Population-Based Follow-Up Study</article-title>. <source>Medicine (Baltimore)</source>. <year>2016</year>;<volume>95</volume>: <fpage>e2300</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MD.0000000000002300">10.1097/MD.0000000000002300</ext-link></comment><pub-id pub-id-type="pmid">26735532</pub-id></mixed-citation></ref><ref id="pone.0160149.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Anuradha</surname><given-names>R</given-names></name>, <name><surname>Munisankar</surname><given-names>S</given-names></name>, <name><surname>Bhootra</surname><given-names>Y</given-names></name>, <name><surname>Kumar</surname><given-names>NP</given-names></name>, <name><surname>Dolla</surname><given-names>C</given-names></name>, <name><surname>Kumaran</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection</article-title>. <source>Clin Vaccine Immunol CVI</source>. <year>2016</year>;<volume>23</volume>: <fpage>339</fpage>&#x02013;<lpage>345</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/CVI.00009-16">10.1128/CVI.00009-16</ext-link></comment>
<pub-id pub-id-type="pmid">26865593</pub-id></mixed-citation></ref><ref id="pone.0160149.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Shaviya</surname><given-names>N</given-names></name>, <name><surname>Budambula</surname><given-names>V</given-names></name>, <name><surname>Webale</surname><given-names>MK</given-names></name>, <name><surname>Were</surname><given-names>T</given-names></name>. <article-title>Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals</article-title>. <source>Interdiscip Perspect Infect Dis</source>. <year>2016</year>;<volume>2016</volume>: <fpage>9415364</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2016/9415364">10.1155/2016/9415364</ext-link></comment>
<pub-id pub-id-type="pmid">26880909</pub-id></mixed-citation></ref><ref id="pone.0160149.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Oliveira</surname><given-names>ES</given-names></name>, <name><surname>Marinho</surname><given-names>JM</given-names></name>, <name><surname>Barbosa</surname><given-names>T</given-names></name>, <collab>study group</collab>. <article-title>Interferon-gamma production by mononuclear cells in Bacille Calmette-Gu&#x000e9;rin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial</article-title>. <source>Vaccine</source>. <year>2013</year>;<volume>31</volume>: <fpage>3778</fpage>&#x02013;<lpage>3782</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vaccine.2013.04.079">10.1016/j.vaccine.2013.04.079</ext-link></comment>
<pub-id pub-id-type="pmid">23684832</pub-id></mixed-citation></ref><ref id="pone.0160149.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Barreto</surname><given-names>ML</given-names></name>, <name><surname>Pereira</surname><given-names>SM</given-names></name>, <name><surname>Pilger</surname><given-names>D</given-names></name>, <name><surname>Cruz</surname><given-names>AA</given-names></name>, <name><surname>Cunha</surname><given-names>SS</given-names></name>, <name><surname>Sant&#x02019;Anna</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial</article-title>. <source>Vaccine</source>. <year>2011</year>;<volume>29</volume>: <fpage>4875</fpage>&#x02013;<lpage>4877</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.vaccine.2011.05.023">10.1016/j.vaccine.2011.05.023</ext-link></comment>
<pub-id pub-id-type="pmid">21616115</pub-id></mixed-citation></ref><ref id="pone.0160149.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Amim</surname><given-names>LHLV</given-names></name>, <name><surname>Pacheco</surname><given-names>AG</given-names></name>, <name><surname>Fonseca-Costa</surname><given-names>J</given-names></name>, <name><surname>Loredo</surname><given-names>CS</given-names></name>, <name><surname>Rabahi</surname><given-names>MF</given-names></name>, <name><surname>Melo</surname><given-names>MH</given-names></name>, <etal>et al</etal>
<article-title>Role of IFN-gamma +874 T/A single nucleotide polymorphism in the tuberculosis outcome among Brazilians subjects</article-title>. <source>Mol Biol Rep</source>. <year>2008</year>;<volume>35</volume>: <fpage>563</fpage>&#x02013;<lpage>566</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11033-007-9123-1">10.1007/s11033-007-9123-1</ext-link></comment>
<pub-id pub-id-type="pmid">17682837</pub-id></mixed-citation></ref><ref id="pone.0160149.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Barros</surname><given-names>AJD</given-names></name>, <name><surname>Hirakata</surname><given-names>VN</given-names></name>. <article-title>Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio</article-title>. <source>BMC Med Res Methodol</source>. <year>2003</year>;<volume>3</volume>: <fpage>21</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2288-3-21">10.1186/1471-2288-3-21</ext-link></comment>
<pub-id pub-id-type="pmid">14567763</pub-id></mixed-citation></ref><ref id="pone.0160149.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>G</given-names></name>. <article-title>A modified poisson regression approach to prospective studies with binary data</article-title>. <source>Am J Epidemiol</source>. <year>2004</year>;<volume>159</volume>: <fpage>702</fpage>&#x02013;<lpage>706</lpage>. <pub-id pub-id-type="pmid">15033648</pub-id></mixed-citation></ref><ref id="pone.0160149.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Bozdogan</surname><given-names>H</given-names></name>. <article-title>Model selection and Akaike&#x02019;s Information Criterion (AIC): The general theory and its analytical extensions</article-title>. <source>Psychometrika</source>. <year>1987</year>;<volume>52</volume>: <fpage>345</fpage>&#x02013;<lpage>370</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/BF02294361">10.1007/BF02294361</ext-link></comment></mixed-citation></ref><ref id="pone.0160149.ref022"><label>22</label><mixed-citation publication-type="other">World Health Organization. WHO | Physical status: the use and interpretation of anthropometry [Internet]. Geneva, Switzerland: World Health Organization; 1995. Report No.: ISSN 0512-3054. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/childgrowth/publications/physical_status/en/">http://www.who.int/childgrowth/publications/physical_status/en/</ext-link></mixed-citation></ref><ref id="pone.0160149.ref023"><label>23</label><mixed-citation publication-type="book"><collab>R Development Core Team</collab>. <chapter-title>R: A language and environment for statistical computing</chapter-title> [Internet]. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>; <year>2011</year> Available: <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link></mixed-citation></ref><ref id="pone.0160149.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Leandro</surname><given-names>ACCS</given-names></name>, <name><surname>Rocha</surname><given-names>MA</given-names></name>, <name><surname>Lamoglia-Souza</surname><given-names>A</given-names></name>, <name><surname>VandeBerg</surname><given-names>JL</given-names></name>, <name><surname>Rolla</surname><given-names>VC</given-names></name>, <name><surname>Bonecini-Almeida</surname><given-names>M da G</given-names></name>. <article-title>No association of IFNG+874T/A SNP and NOS2A-954G/C SNP variants with nitric oxide radical serum levels or susceptibility to tuberculosis in a Brazilian population subset</article-title>. <source>BioMed Res Int</source>. <year>2013</year>;<volume>2013</volume>: <fpage>901740</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2013/901740">10.1155/2013/901740</ext-link></comment>
<pub-id pub-id-type="pmid">24024215</pub-id></mixed-citation></ref><ref id="pone.0160149.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Muller</surname><given-names>BLA</given-names></name>, <name><surname>Ramalho</surname><given-names>DM de P</given-names></name>, <name><surname>Santos</surname><given-names>PFG dos</given-names></name>, <name><surname>Mesquita</surname><given-names>EDD</given-names></name>, <name><surname>Kritski</surname><given-names>AL</given-names></name>, <name><surname>Oliveira</surname><given-names>MM</given-names></name>. <article-title>Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis</article-title>. <source>J Bras Pneumol Publica&#x000e7;a&#x000e4;o Of Soc Bras Pneumol E Tisilogia</source>. <year>2013</year>;<volume>39</volume>: <fpage>719</fpage>&#x02013;<lpage>727</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S1806-37132013000600011">10.1590/S1806-37132013000600011</ext-link></comment>
<pub-id pub-id-type="pmid">24473766</pub-id></mixed-citation></ref><ref id="pone.0160149.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Lio</surname><given-names>D</given-names></name>, <name><surname>Marino</surname><given-names>V</given-names></name>, <name><surname>Serauto</surname><given-names>A</given-names></name>, <name><surname>Gioia</surname><given-names>V</given-names></name>, <name><surname>Scola</surname><given-names>L</given-names></name>, <name><surname>Crivello</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Genotype frequencies of the +874T&#x02014;&#x0003e;A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis</article-title>. <source>Eur J Immunogenetics Off J Br Soc Histocompat Immunogenetics</source>. <year>2002</year>;<volume>29</volume>: <fpage>371</fpage>&#x02013;<lpage>374</lpage>.</mixed-citation></ref><ref id="pone.0160149.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Ansari</surname><given-names>A</given-names></name>, <name><surname>Talat</surname><given-names>N</given-names></name>, <name><surname>Jamil</surname><given-names>B</given-names></name>, <name><surname>Hasan</surname><given-names>Z</given-names></name>, <name><surname>Razzaki</surname><given-names>T</given-names></name>, <name><surname>Dawood</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients</article-title>. <source>PloS One</source>. <year>2009</year>;<volume>4</volume>: <fpage>e4778</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0004778">10.1371/journal.pone.0004778</ext-link></comment>
<pub-id pub-id-type="pmid">19274101</pub-id></mixed-citation></ref><ref id="pone.0160149.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Selvaraj</surname><given-names>P</given-names></name>, <name><surname>Alagarasu</surname><given-names>K</given-names></name>, <name><surname>Harishankar</surname><given-names>M</given-names></name>, <name><surname>Vidyarani</surname><given-names>M</given-names></name>, <name><surname>Nisha</surname><given-names>Rajeswari D</given-names></name>, <name><surname>Narayanan</surname><given-names>PR</given-names></name>. <article-title>Cytokine gene polymorphisms and cytokine levels in pulmonary tuberculosis</article-title>. <source>Cytokine</source>. <year>2008</year>;<volume>43</volume>: <fpage>26</fpage>&#x02013;<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cyto.2008.04.011">10.1016/j.cyto.2008.04.011</ext-link></comment>
<pub-id pub-id-type="pmid">18522869</pub-id></mixed-citation></ref><ref id="pone.0160149.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Vidyarani</surname><given-names>M</given-names></name>, <name><surname>Selvaraj</surname><given-names>P</given-names></name>, <name><surname>Prabhu</surname><given-names>Anand S</given-names></name>, <name><surname>Jawahar</surname><given-names>MS</given-names></name>, <name><surname>Adhilakshmi</surname><given-names>AR</given-names></name>, <name><surname>Narayanan</surname><given-names>PR</given-names></name>. <article-title>Interferon gamma (IFNgamma) &#x00026; interleukin-4 (IL-4) gene variants &#x00026; cytokine levels in pulmonary tuberculosis</article-title>. <source>Indian J Med Res</source>. <year>2006</year>;<volume>124</volume>: <fpage>403</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="pmid">17159260</pub-id></mixed-citation></ref><ref id="pone.0160149.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Bream</surname><given-names>JH</given-names></name>, <name><surname>Ping</surname><given-names>A</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Winkler</surname><given-names>C</given-names></name>, <name><surname>Young</surname><given-names>HA</given-names></name>. <article-title>A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription</article-title>. <source>Genes Immun</source>. <year>2002</year>;<volume>3</volume>: <fpage>165</fpage>&#x02013;<lpage>169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.gene.6363870">10.1038/sj.gene.6363870</ext-link></comment>
<pub-id pub-id-type="pmid">12070781</pub-id></mixed-citation></ref><ref id="pone.0160149.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Jabot-Hanin</surname><given-names>F</given-names></name>, <name><surname>Cobat</surname><given-names>A</given-names></name>, <name><surname>Feinberg</surname><given-names>J</given-names></name>, <name><surname>Grange</surname><given-names>G</given-names></name>, <name><surname>Remus</surname><given-names>N</given-names></name>, <name><surname>Poirier</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Major Loci on Chromosomes 8q and 3q Control Interferon &#x003b3; Production Triggered by Bacillus Calmette-Guerin and 6-kDa Early Secretory Antigen Target, Respectively, in Various Populations</article-title>. <source>J Infect Dis</source>. <year>2016</year>;<volume>213</volume>: <fpage>1173</fpage>&#x02013;<lpage>1179</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiv757">10.1093/infdis/jiv757</ext-link></comment>
<pub-id pub-id-type="pmid">26690346</pub-id></mixed-citation></ref><ref id="pone.0160149.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Zheng</surname><given-names>T</given-names></name>, <name><surname>Lan</surname><given-names>Q</given-names></name>, <name><surname>Foss</surname><given-names>F</given-names></name>, <name><surname>Kim</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma</article-title>. <source>Blood</source>. <year>2011</year>;<volume>117</volume>: <fpage>585</fpage>&#x02013;<lpage>590</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2010-07-295097">10.1182/blood-2010-07-295097</ext-link></comment>
<pub-id pub-id-type="pmid">20952689</pub-id></mixed-citation></ref><ref id="pone.0160149.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>Y</given-names></name>, <name><surname>Ma</surname><given-names>A</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Cai</surname><given-names>J</given-names></name>, <name><surname>Schouten</surname><given-names>EG</given-names></name>, <etal>et al</etal>
<article-title>Relation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitus</article-title>. <source>PloS One</source>. <year>2013</year>;<volume>8</volume>: <fpage>e80122</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0080122">10.1371/journal.pone.0080122</ext-link></comment>
<pub-id pub-id-type="pmid">24260344</pub-id></mixed-citation></ref></ref-list></back></article>